BioPharma Credit PLC
BOPCF
$0.96
$0.011.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 28.55M | 28.55M | 36.39M | 36.39M | 25.17M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.45M | -5.45M | -3.33M | -3.33M | -2.37M |
| Change in Net Operating Assets | 5.57M | 5.57M | -16.19M | -16.19M | 9.33M |
| Cash from Operations | 28.67M | 28.67M | 16.88M | 16.88M | 32.13M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.74M | 3.74M | 35.00M | 35.00M | -500.00 |
| Cash from Investing | 3.74M | 3.74M | 35.00M | 35.00M | -500.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -45.00K | -45.00K | -25.59M | -25.59M | -14.56M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -19.76M | -19.76M | -20.22M | -20.22M | -8.11M |
| Other Financing Activities | -8.47M | -8.47M | -6.74M | -6.74M | -25.22M |
| Cash from Financing | -28.28M | -28.28M | -52.55M | -52.55M | -47.90M |
| Foreign Exchange rate Adjustments | 6.00K | 6.00K | 12.50K | 12.50K | -1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.14M | 4.14M | -657.50K | -657.50K | -15.76M |